Kresse SH, Brandt-Winge S, Pharo H, Flatin BTB, Jeanmougin M, Vedeld HM, Lind GE(2023) Evaluation of commercial kits for isolation and bisulfite conversion of circulating cell-free tumor DNA from blood Clin Epigenetics, 15(1), 151 DOI 10.1186/s13148-023-01563-0, PubMed 37710283
Bogaard M, Skotheim RI, Maltau AV, Kidd SG, Lothe RA, Axcrona K, Axcrona U(2023) 'High proliferative cribriform prostate cancer' defines a patient subgroup with an inferior prognosis Histopathology(in press) DOI 10.1111/his.15012, PubMed 37501635
